Browsing All Posts published on »May 16th, 2012«

Eli Lilly Fined 1.4 billion for Promoting Zyprexa for use with Alzheimer’s and Dementia Patients

May 16, 2012


American pharmaceutical giant Eli Lilly and Company agreed to plead guilty and pay $1.415 billion for promoting its drug Zyprexa® for uses not approved by the Food and Drug Administration (FDA), the Department of Justice announced. This resolution includes a criminal fine of $515 million, the largest ever in a health care case, and the largest […]

Abbott Labs Fined $1.6 Billion for Sedating Dementia Patients with Depakote

May 16, 2012


WASHINGTON, DC –  In the second largest payment ever enforced involving off-label misuse of a single drug, the U.S. Justice Department  reached a $1.6 billion settlement with Abbott Laboratories over its illegal marketing of antiepileptic medication Depakote to pediatric and geriatric patients. The settlement was reached between Abbott and the Justice Department, along with private […]